摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(4-bromophenyl)(toluene-4-sulfonyl)methyl]formamide | 655254-74-3

中文名称
——
中文别名
——
英文名称
N-[(4-bromophenyl)(toluene-4-sulfonyl)methyl]formamide
英文别名
N-[(4-bromophenyl)-(4-methylphenyl)sulfonylmethyl]formamide
N-[(4-bromophenyl)(toluene-4-sulfonyl)methyl]formamide化学式
CAS
655254-74-3
化学式
C15H14BrNO3S
mdl
——
分子量
368.251
InChiKey
BVCWSAQVSPBQLY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    71.6
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    N-[(4-bromophenyl)(toluene-4-sulfonyl)methyl]formamide2,6-二甲基吡啶 、 oxone 、 potassium carbonate三氯氧磷 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 66.0h, 生成 Tert-butyl 4-[4-(4-bromophenyl)-5-[2-(3,5-dimethylanilino)pyrimidin-4-yl]imidazol-1-yl]piperidine-1-carboxylate
    参考文献:
    名称:
    A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes
    摘要:
    DOI:
    10.1021/acs.jmedchem.1c01779
  • 作为产物:
    描述:
    {(3-iodophenyl)[(4-methylphenyl)sulfonyl]methyl}formamide 、 对溴苯甲醛 、 生成 N-[(4-bromophenyl)(toluene-4-sulfonyl)methyl]formamide
    参考文献:
    名称:
    Condensed pyridines and pyrimidines with tie2 (tek) activity
    摘要:
    化合物的式子(I),其中A与其连接的碳原子一起形成一个融合的5元杂环芳基环,其中该杂环芳基环含有1或2个从O,N和S中选择的杂原子,并且含有G的5元环与在式子(I)中被标记为#的桥头碳上的A形成的环在间位连接:G从O,S和NR5中选择;Z从N和CR6中选择;Q1从可选取代的芳基和杂环基中选择,取代基R1到R6如文本中所定义,用于在温血动物如人中产生抗血管生成效应的制备。
    公开号:
    US20050256140A1
点击查看最新优质反应信息

文献信息

  • Catalytic Enantioselective Addition of Organometallic Reagents to <i>N</i>-Formylimines Using Monodentate Phosphoramidite Ligands
    作者:Maria Gabriella Pizzuti、Adriaan J. Minnaard、Ben L. Feringa
    DOI:10.1021/jo702140f
    日期:2008.2.1
    The asymmetric synthesis of protected amines via the copper/phosphoramidite-catalyzed addition of organozinc and organoaluminum reagents to N-acylimines, generated in situ from aromatic and aliphatic α-amidosulfones, is reported. High yields of optically active N-formyl-protected amines and enantioselectivities up to 99% were obtained. Under the reaction conditions, partial oxidation of the phosphoramidite
    据报道,通过芳族和脂肪族α-酰胺基砜原位生成的铜/次膦酸酯催化的有机锌和有机铝试剂向N-酰基嘧啶的加成反应,不对称合成了受保护的胺。获得了高产率的旋光性N-甲酰基保护的胺,对映选择性高达99%。在反应条件下,检测到亚磷酰胺配体被部分氧化为相应的磷酸酰胺。初步研究了其起源及其对催化加成反应的影响。
  • [EN] CONDENSED PYRIDINES AND PYRIMIDINES WITH TIE2 (TEK) ACTIVITY<br/>[FR] PYRIDINES CONDENSEES ET PYRIMIDINES A ACTIVITE TIE2 (TEK)
    申请人:ASTRAZENECA AB
    公开号:WO2004013141A1
    公开(公告)日:2004-02-12
    A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G is linked to the ring formed by A in the meta position to the bridgehead carbon marked # in Formula (I); G is selected from O, S and NR5; Z is selected from N and CR6; Q1 is selected from optionally substituted aryl and heteroaryl, and the substituents R1 to R6 are as defined in the text for use in the production of an anti-angiogenic effect in a warm blooded animal such as man.
    化合物的公式(I),其中A与其连接的碳原子一起形成一个融合的5-成员杂环芳烃环,其中所述的杂环芳烃环包含1个或2个从O、N和S中选择的杂原子,并且包含G的5-成员环与在公式(I)中标记为桥头碳#的A形成的环在间位连接;G从O、S和NR5中选择;Z从N和CR6中选择;Q1从可选择的取代芳基和杂环芳基中选择,取代基R1到R6如文本中所定义,用于在温血动物(如人)中产生抗血管生成作用。
  • Development of Chiral Catalysts by Asymmetric Activation for Highly Enantioselective Diethylzinc Addition to Imines
    作者:Liu-Zhu Gong、Hai-Le Zhang、Hua Liu、Xin Cui、Ai-Qiao Mi、Yao-Zhong Jiang
    DOI:10.1055/s-2005-863709
    日期:——
    derived from chiral 1,2-diphenyl-ethanene-1,2-diamine, BINOL derivatives, and diethylzinc are evaluated in the asymmetric addition of diethylzinc to N-acylimines. In the presence of 10 mol% L3ZnAl, high enantioselectivities and yields were provided for a wide range of aromatic imines in 1,2-dichloroethane at -25 °C.
    基于不对称活化概念,在不对称加成中评估了由衍生自手性 1,2-二苯基-乙烷-1,2-二胺、BINOL 衍生物和二乙基锌的二亚胺组合形成的原位手性锌配合物库二乙基锌转化为 N-酰基亚胺。在 10 mol% L3ZnAl 存在下,在 -25 °C 下,1,2-二氯乙烷中的多种芳族亚胺均具有高对映选择性和产率。
  • Condensed pyridines and pyrimidines with tie2 (tek) activity
    申请人:Luke Arthur Richard William
    公开号:US20050256140A1
    公开(公告)日:2005-11-17
    A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G is linked to the ring formed by A in the meta position to the bridgehead carbon marked # in Formula (I): G is selected from O, S and NR 5 ; Z is selected from N and CR 6 ; Q 1 is selected from optionally substituted aryl and heteroaryl, and the substituents R 1 to R 6 are as defined in the text for use in the production of an anti-angiogenic effect in a warm blooded animal such as man.
    化合物的式子(I),其中A与其连接的碳原子一起形成一个融合的5元杂环芳基环,其中该杂环芳基环含有1或2个从O,N和S中选择的杂原子,并且含有G的5元环与在式子(I)中被标记为#的桥头碳上的A形成的环在间位连接:G从O,S和NR5中选择;Z从N和CR6中选择;Q1从可选取代的芳基和杂环基中选择,取代基R1到R6如文本中所定义,用于在温血动物如人中产生抗血管生成效应的制备。
  • Discovery of chiral catalysts by asymmetric activation for highly enantioselective diethylzinc addition to imines: using racemic and achiral diimines as effective activators
    作者:Hua Liu、Hai-Le Zhang、Shuang-Jun Wang、Ai-Qiao Mi、Yao-Zhong Jiang、Liu-Zhu Gong
    DOI:10.1016/j.tetasy.2005.07.014
    日期:2005.9
    A library of chiral zinc complexes formed in Situ by the combination of achiral and racemic diimines with 3,3'-di(3,5-ditrifluoromethylphenyl)-BINOL and diethylzinc were evaluated in the asymmetric addition of diethylzine to N-acylimines. In the presence of 10 mol % of chiral ligand 4 and racemic diimine 5, high enantioselectivities of up to 97% ee and yields of up to 96% were achieved for a wide range of aromatic imines in dichloromethane at -30 degrees C. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐